Skip to content
ECI Therapeutics
  • about eci
    • our mission
    • our team
    • careers
  • platform
    • platelet-rich plasma & growth factors
    • hyaluronic acid & chitosan
    • product safety
    • process
  • products
    • ophthalmic products
    • pipeline
  • disease states
    • ocular diseases
    • wound and ulcer care
    • mucosal membrane dryness
  • investors
    • addressable population
    • target product profile
    • data room
  • contact us
Search
ECI Therapeutics
  • about eci
    • our mission
    • our team
    • careers
  • platform
    • platelet-rich plasma & growth factors
    • hyaluronic acid & chitosan
    • product safety
    • process
  • products
    • ophthalmic products
    • pipeline
  • disease states
    • ocular diseases
    • wound and ulcer care
    • mucosal membrane dryness
  • investors
    • addressable population
    • target product profile
    • data room
  • contact us

test

Download – members and redirect to file

By ecitherapeutic

Download – members and redirect to file Read More »

Test Download – with email lock

By ecitherapeutic

This is a short description

Test Download – with email lock Read More »

ECI researches, develops, and creates breakthrough products – in ophthalmics, wound healing, and burn care – that leverage blood and chitosan to help patients, their family and their community see clearly and lead healthier lives.

ECI Therapeutics products are not FDA approved.

Follow Us

  • LinkedIn
investor Data Room
(Login Required)

eci logo bar

 

ECI researches, develops, and creates breakthrough products – in ophthalmics, wound healing, and burn care – that leverage blood and chitosan to help patients, their family and their community see clearly and lead healthier lives.

ECI Therapeutics products are not FDA approved.

 

Investor Data Room
(Login Required)
Linkedin

Content herein may contain certain forward-looking statements relating to Eye Care International, DBA ECI Therapeutics (ECI), that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to ECI’s management. These forward-looking statements are, by their nature, subject to significant risks and uncertainties. These forward-looking statements include, without limitation, statements relating to the Company’s business prospects, future developments, possible mergers and acquisitions activity, trends and conditions in the industry, its strategies, plans, objectives and goals, its ability to control costs, statements relating to prices, volumes, operations, margins, overall market trends, risk management and exchange rates. As a result of various risks, uncertainties and assumptions, forward-looking events and circumstances discussed herein might not occur in the way ECI expects, or at all. Accordingly, you should not place reliance on any forward-looking information or statements. All forward-looking statements herein are qualified by reference to the cautionary statements set forth in this disclaimer.

 

Legal   Cookie policy   Privacy policy

Copyright © 2025 ECI Therapeutics.
ECI Therapeutics is a trademark of Eye Care International (DBA ECI Therapeutics), LLC.

Content herein may contain certain forward-looking statements relating to Eye Care International, DBA ECI Therapeutics (ECI), that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to ECI’s management. These forward-looking statements are, by their nature, subject to significant risks and uncertainties. These forward-looking statements include, without limitation, statements relating to the Company’s business prospects, future developments, possible mergers and acquisitions activity, trends and conditions in the industry, its strategies, plans, objectives and goals, its ability to control costs, statements relating to prices, volumes, operations, margins, overall market trends, risk management and exchange rates. As a result of various risks, uncertainties and assumptions, forward-looking events and circumstances discussed herein might not occur in the way ECI expects, or at all. Accordingly, you should not place reliance on any forward-looking information or statements. All forward-looking statements herein are qualified by reference to the cautionary statements set forth in this disclaimer.

  • legal
  • cookie policy
  • privacy policy

Copyright © 2025 ECI Therapeutics.
ECI Therapeutics is a trademark of Eye Care International (DBA ECI Therapeutics), LLC.